Aerovate Therapeutics Inc
NASDAQ:AVTE
Income Statement
Earnings Waterfall
Aerovate Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-81.4m
USD
|
Operating Income
|
-81.4m
USD
|
Other Expenses
|
5.9m
USD
|
Net Income
|
-75.5m
USD
|
Income Statement
Aerovate Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(9)
|
(11)
|
(15)
|
(18)
|
(23)
|
(31)
|
(38)
|
(46)
|
(53)
|
(60)
|
(68)
|
(75)
|
(81)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(3)
|
(5)
|
(8)
|
(11)
|
(14)
|
(14)
|
(15)
|
(15)
|
(15)
|
(17)
|
(17)
|
|
Research & Development |
(8)
|
(9)
|
(12)
|
(13)
|
(15)
|
(20)
|
(24)
|
(31)
|
(39)
|
(45)
|
(53)
|
(59)
|
(64)
|
|
Operating Income |
(9)
N/A
|
(11)
-23%
|
(15)
-33%
|
(18)
-27%
|
(23)
-25%
|
(31)
-36%
|
(38)
-21%
|
(46)
-21%
|
(53)
-17%
|
(60)
-12%
|
(68)
-14%
|
(75)
-11%
|
(81)
-8%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
6
|
|
Total Other Income |
(1)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(10)
N/A
|
(11)
-14%
|
(15)
-33%
|
(18)
-27%
|
(23)
-25%
|
(31)
-35%
|
(37)
-20%
|
(45)
-20%
|
(51)
-15%
|
(57)
-11%
|
(64)
-12%
|
(70)
-9%
|
(75)
-8%
|
|
Net Income | ||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(10)
|
(11)
|
(15)
|
(18)
|
(23)
|
(31)
|
(37)
|
(45)
|
(52)
|
(57)
|
(64)
|
(70)
|
(76)
|
|
Net Income (Common) |
(10)
N/A
|
(11)
-14%
|
(15)
-32%
|
(19)
-26%
|
(23)
-24%
|
(31)
-35%
|
(37)
-20%
|
(45)
-20%
|
(52)
-15%
|
(57)
-11%
|
(64)
-12%
|
(70)
-9%
|
(76)
-8%
|
|
EPS (Diluted) |
-0.42
N/A
|
-0.49
-17%
|
-0.64
-31%
|
-0.81
-27%
|
-0.99
-22%
|
-1.27
-28%
|
-1.52
-20%
|
-1.82
-20%
|
-2.1
-15%
|
-2.3
-10%
|
-2.54
-10%
|
-2.53
+0%
|
-2.87
-13%
|